Top 2
Alternative Names: Top-2Latest Information Update: 11 Mar 2024
At a glance
- Originator Imagine Pharma
- Class
- Mechanism of Action Epithelial cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I Wounds
Most Recent Events
- 06 Feb 2024 Top 2 is available for licensing as of 06 Feb 2024. https://imaginepharma.com/platforms/therapeutics/ (Imagine pharma pipeline, February 2024)
- 06 Feb 2024 Phase-I clinical trials in Wounds (Topical), prior to February 2024 (Imagine pharma pipeline, February 2024)
- 06 Feb 2024 Preclinical trials in Wounds in USA (Topical), prior to February 2024 (Imagine pharma pipeline, February 2024)